Logo do repositório
 
Publicação

New antivirals against herpes virus and HIV

dc.contributor.authorValdeira, Maria Luísa
dc.contributor.authorGonçalves, João
dc.date.accessioned2017-08-23T17:13:20Z
dc.date.available2017-08-23T17:13:20Z
dc.date.issued2005
dc.description.abstractIn recent years, the demand for new antiviral compounds has increased markdly. There are many contributing factors to this increased demand, including the ever-increasing prevalence of chronic viral injections such as HIV and heRpes viruses and it is important to inactivate these viruses, because the viral strains are resislant to drugs employed in the treatment of infections. In our Iaboratory, we have studied many types of new compounds as antivirals agents from plants used in African traditional medicine, plants of lhe Portuguese flora and synthesis of new severa types of compounds. In this moment, the antiviral research has been done with new synthesized porphyrin derivatives that are photosensilizers useful to photodynamic therapy. In addilion, catechois from abietic acid were prepared and evaluated for antiviral activity. Their properties were compared with those of carnosic acid, a natural-occurring catechol possessing an abietane skeleton and known as a potent antioxidant with anticancer and antiviral properties.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationPandalai SG, editor. Recent research developments in infection & immunity. Kerala: Transworld Research Network; 2005. p. 1-10pt_PT
dc.identifier.isbn81-7895-182-7
dc.identifier.urihttp://hdl.handle.net/10451/28758
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherTransworld Research Networkpt_PT
dc.relation.publisherversionVogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002. p. 93-113pt_PT
dc.titleNew antivirals against herpes virus and HIVpt_PT
dc.typebook part
dspace.entity.typePublication
oaire.citation.endPage10pt_PT
oaire.citation.startPage1pt_PT
oaire.citation.titleRecent research developments in infection & immunitypt_PT
oaire.citation.volume3pt_PT
rcaap.rightsrestrictedAccesspt_PT
rcaap.typebookPartpt_PT

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
12846.pdf
Tamanho:
800.2 KB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.2 KB
Formato:
Item-specific license agreed upon to submission
Descrição: